|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Reduction of operating lease right-of-use assets | |||||
| Loss on impairment, receivables and sale or disposal of equipment | |||||
| Stock-based compensation | |||||
| Amortization of debt issuance costs | |||||
| Deferred tax assets | |||||
| Deferred tax liabilities | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| Total accounts receivable, net | |||||
| Settlement assets, net | |||||
| Prepaid expenses | |||||
| Related party loan receivable | |||||
| Other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Settlement liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Proceeds from sale or disposal of property and equipment | |||||
| Software development costs | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Principal payments of finance leases | |||||
| Principal payments of outstanding debt | |||||
| Proceeds from term loan | |||||
| Vesting of restricted common stock | |||||
| Proceeds from initial public offering, net of underwriters' discounts, commissions and offering costs | |||||
| Payments for debt issuance costs | |||||
| Repurchases of early exercised stock options | |||||
| Proceeds from common stock purchased under Matching Plan | |||||
| Proceeds from issuance of common stock on exercise of stock options | |||||
| Payments for employee taxes withheld from stock-based awards | |||||
| Repurchase and retirement of common stock | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Noncash investing and financing items: | |||||
| Stock-based compensation capitalized as software development costs | |||||
| Purchases of property and equipment and capitalized software in accounts payable and accrued expenses | |||||
| Right-of-use assets acquired through operating leases | |||||
| Right-of-use assets acquired through finance leases | |||||
| Fair value of common stock issued to settle liability-classified restricted stock units | |||||
| Cashless exercise of stock options | |||||
| Reconciliation of cash and cash equivalents and restricted cash to the Consolidated Balance Sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other current assets | |||||
| Restricted cash included in other assets | |||||
| Restricted cash included in settlement assets, net | |||||
Loading...